当前位置:主页 > 医学论文 > 妇产科论文 >

透景HPV检测试剂在高危HPV DNA检测及宫颈上皮内瘤变筛查中的应用

发布时间:2019-02-16 05:23
【摘要】:目的评价国产透景试剂(透景HPV)用于HR-HPV DNA检测及宫颈病变诊断的有效性和可行性。方法 602例来自医院门诊健康体检的妇女或者宫颈上皮内瘤变(CIN)住院治疗的患者,经病理学明确诊断。采用透景试剂和Roche试剂(cobas HPV)平行检测子宫颈脱落细胞标本,比较两种方法的一致性。以病理诊断结果作为金标准,评估透景试剂和Roche试剂筛查子宫颈上皮内瘤变的敏感性和特异性。结果透景试剂与Roche试剂总一致率为94.62%(Kappa=0.881),阳性一致率为96.85%,阴性一致率为90.53%;透景试剂与Roche试剂HPV16、HPV18及其他12种高危型HPV的总一致率分别为95.92%(Kappa=0.906),98.70%(Kappa=0.885)和92.76%(Kappa=0.805)。校正后两种检测的总一致率为98.51%(Kappa=0.967),阳性一致率为98.87%,阴性一致率为97.81%;校正后HPV16,HPV18及其他12种高危型HPV的总一致率分别为97.40%(Kappa=0.940),100%(Kappa=1.00)和97.58%(Kappa=0.950)。透景试剂筛查CIN2+的敏感性和特异性分别为91.52%和52.06%,Roche试剂筛查CIN2+的敏感性和特异性分别为91.52%和54.29%,无统计学差异(P0.05)。结论国产透景试剂与进口Roche试剂检测HR-HPV的一致性高,是有效的HPV DNA检测方法,可用于人群中宫颈癌和癌前病变的筛查。
[Abstract]:Objective to evaluate the effectiveness and feasibility of domestic HPV for detection of HR-HPV DNA and diagnosis of cervical lesions. Methods 602 patients with cervical intraepithelial neoplasia (CIN) were diagnosed by pathology. Parallel detection of exfoliated cells of cervix with Roche reagent and Roche reagent was used to compare the consistency of the two methods. The sensitivity and specificity of screening cervical intraepithelial neoplasia were evaluated with the diagnostic results of pathology and Roche reagent. Results the total consistent rate of Roche reagent and transparent reagent was 94.62% (Kappa=0.881), the positive consistency rate was 96.85 and the negative consistency rate was 90.53%. The concordance rates of permeation reagent with Roche reagent, HPV16,HPV18 and other 12 high risk HPV were 95.92% (Kappa=0.906), 98.70% (Kappa=0.885) and 92.76% (Kappa=0.805), respectively. After correction, the total consistency rate of the two tests was 98.51% (Kappa=0.967), the positive consistency rate was 98.87%, and the negative consistency rate was 97.81%. The total consistent rates of HPV16,HPV18 and other high risk HPV were 97.40% (Kappa=0.940), 100% (Kappa=1.00) and 97.58% (Kappa=0.950), respectively. The sensitivity and specificity of roche reagent in screening CIN2 were 91.52% and 52.06%, respectively. The sensitivity and specificity of Roche reagent were 91.52% and 54.29%, respectively. There was no statistical difference (P0.05). Conclusion there is a high consistency between domestic and imported Roche reagent for detection of HR-HPV, which is an effective method for HPV DNA detection and can be used for screening cervical cancer and precancerous lesions in the population.
【作者单位】: 北京协和医学院/中国医学科学院肿瘤医院流行病学研究室;大连医科大学公共卫生学院流行病与卫生统计学教研室;
【分类号】:R737.33

【相似文献】

相关期刊论文 前10条

1 袁路;张富青;刘敏;徐广立;;母体外周血胎儿游离DNA检测在临床诊断中的应用[J];中国医学工程;2014年02期

2 叶春红;;宫颈癌患者DNA检测的临床意义[J];河北医学;2010年11期

3 王传霞;顾茂胜;;血清学筛查与无创DNA检测在产前诊断胎儿染色体异常中的应用[J];中国优生与遗传杂志;2014年06期

4 王召娟;段仙芝;;高危型HPV-DNA检测在内蒙古准格尔旗宫颈癌初级筛查中的意义[J];内蒙古医学杂志;2014年06期

5 杨雪;徐琴燕;赵敏;;宫颈病变应用高危型HPV-DNA检测联合TCT方法的效果研究[J];中国妇幼保健;2014年24期

6 董小平,袁育康,房益兰,刘延娜,楚雍烈,任会勋;尖锐湿疣中人乳头瘤病毒DNA检测及存在情况初探[J];西安交通大学学报(医学版);1992年02期

7 王琼瑶;宋志娇;周围;谢晓东;童晓文;纪亚忠;;用母体外周血中胎儿游离DNA检测胎儿SRY基因的研究[J];同济大学学报(医学版);2013年05期

8 刘娜;付睿婷;阿曼古丽;王英红;;细胞学结合高危型HPV-DNA检测在宫颈病变筛查中的应用[J];现代生物医学进展;2010年07期

9 袁艺;秦杰;;阴道镜和高危型人乳头状瘤病毒-DNA检测筛查宫颈不典型病变的临床研究[J];医学综述;2014年10期

10 何秋玲;刘冬艳;;TCT联合高危型HPV-DNA检测在宫颈病变筛查中的应用[J];中国卫生产业;2012年12期

相关硕士学位论文 前1条

1 孙颖;人乳头瘤病毒DNA检测用于宫颈癌盆腔淋巴结转移预测的研究[D];南方医科大学;2007年



本文编号:2424091

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/fuchankeerkelunwen/2424091.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户7b71e***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com